Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Studying both sexes: a guiding principle for biomedicine.
EMD Serono Takes on Exclusive Promotion of Rebif® (interferon beta-1a) in the US
Pervasive Axonal Transport Deficits in Multiple Sclerosis Models.
Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation.
Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial.
Foxp3(+) Treg cells in the inflamed CNS are insensitive to IL-6-driven IL-17 production.
Effects of delayed-release dimethyl fumarate on MRI measures in the Phase 3 DEFINE study.
A much-needed focus on progression in multiple sclerosis.
Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 months.
Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Long-term follow-up of a phase 2 study of oral teriflunomide in relapsing multiple sclerosis: safety and efficacy results up to 8.5 years.
Patterns of Treatment Switching in Multiple Sclerosis Therapies in US Patients Active on Social Media: Application of Social Media Content Analysis to Health Outcomes Research.
Astrocyte-derived lactosylceramide implicated in multiple sclerosis.
Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study.
The brain antigen-specific B cell response correlates with glatiramer acetate responsiveness in relapsing-remitting multiple sclerosis patients.
Reversible pulmonary artery hypertension in association with interferon-beta therapy for multiple sclerosis.
US and EU regulatory authorities accept PLEGRIDY™ (peginterferon beta-1a) marketing applications for review
Interplay between exercise and dietary fat modulates myelinogenesis in the central nervous system.
Severe liver dysfunction possibly caused by the combination of interferon beta-1b therapy and melilot (sweet clover) supplement.
Risk of natalizumab-associated progressive multifocal leukoencephalopathy.
Association of Immunotherapies With Outcomes in Relapsing-Remitting Multiple Sclerosis.
Regulation of prefrontal cortex myelination by the microbiota.
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines.
PHENYTEK®* Capsules (extended phenytoin sodium capsules, USP)
Glatiramer Acetate and Nanny Proteins Restrict Access of the Multiple Sclerosis Autoantigen Myelin Basic Protein to the 26S Proteasome.

Pages